Evidence map›Paper›PMID 42626152›Full record

ArticleWorld journal of clinical pediatrics2026

Patient satisfaction and performance of the A8+ TouchCare Nano in children and adolescents with type 1 diabetes mellitus.

Konstantina Kosta, Maria G Grammatikopoulou, Ilektra Toulia, Penelope Smyrnaki, Eleni G Paschalidou, Anastasios Vamvakis, Antonios Bogiatzoglou, Christos Tzimos, Kyriaki Tsiroukidou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Konstantina KostaPediatric Endocrinology Unit, 3 Department of Pediatrics, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki GR-54124, Kentrikí Makedonía, Greece.
Maria G GrammatikopoulouImmunonutrition and Clinical Nutrition Unit, Department of Rheumatology and Clinical Immunology, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis Campus, Larissa GR-41223, Greece. mgrammat@uth.gr.
Ilektra TouliaPediatric Endocrinology Unit, 3 Department of Pediatrics, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki GR-54124, Kentrikí Makedonía, Greece.
Penelope SmyrnakiPediatric Endocrinology Clinic, Heraclion GR-71303, Greece.
Eleni G PaschalidouPediatric Endocrinology Unit, 3 Department of Pediatrics, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki GR-54124, Kentrikí Makedonía, Greece.
Anastasios VamvakisDepartment of Nutritional Sciences and Dietetics, Hellenic Mediterranean University, Siteia GR-72300, Kríti, Greece.
Antonios BogiatzoglouPediatric Endocrinology Unit, 3 Department of Pediatrics, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki GR-54124, Kentrikí Makedonía, Greece.
Christos TzimosNorthern Greece Statistics Directorate, Hellenic Statistical Authority, Thessaloniki GR-54646, Kentrikí Makedonía, Greece.
Kyriaki TsiroukidouPediatric Endocrinology Unit, 3 Department of Pediatrics, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki GR-54124, Kentrikí Makedonía, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of automated insulin delivery systems in type 1 diabetes mellitus (T1DM) is constantly expanding, merging continuous glucose monitoring readings with a control algorithm and a continuous subcutaneous insulin infusion device,

aimTo evaluate the effectiveness of a new, open and closed-loop insulin delivery system in children and adolescents with T1DM.

methodsChildren and adolescents with T1DM (

resultsThe results showed increased patient satisfaction with the continuous subcutaneous insulin infusion, in particular when the closed-loop system was integrated. Participants were satisfied with most of the system's features, including the predictive low glucose suspend feature, aiming in preventing hypoglycemic episodes and the Auto Meal Handling feature, adjusting the carbohydrate content of each meal without necessitating carbohydrate counting. Time in range, glycosylated haemoglobin levels glucose management indicator, time above range, very high glucose levels, time in tight range and average blood glucose levels were improved after the introduction of the new system. The results remained similar even when closed/open loop systems were evaluated, or when the sample was divided in pre-pubertal/pubescent participants. No adverse events were recorded.

conclusionThe results indicate the that Medtrum A8+ TouchCare Nano system is safe and effective in maintaining and improving glycemic control in children and adolescents with T1DM. More research on pediatric patients is required to further verify these results.

Indexed as

Artificial intelligenceArtificial pancreasAutomated insulin deliveryGlycemic controlMedical deviceTime in rangeType 1 diabetes mellitus

Identifiers

PMID42626152
PMCPMC13491102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.